nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—Bepridil—hypertension	0.41	1	CrCtD
Cyclizine—Trimethaphan—Bepridil—hypertension	0.0354	0.135	CrCrCtD
Cyclizine—Ifenprodil—Bepridil—hypertension	0.031	0.118	CrCrCtD
Cyclizine—Ifenprodil—Labetalol—hypertension	0.0261	0.0999	CrCrCtD
Cyclizine—CYP2C9—Eprosartan—hypertension	0.0203	0.125	CbGbCtD
Cyclizine—Antazoline—Bepridil—hypertension	0.019	0.0725	CrCrCtD
Cyclizine—Eprazinone—Bepridil—hypertension	0.019	0.0725	CrCrCtD
Cyclizine—CYP2C9—Torasemide—hypertension	0.0166	0.102	CbGbCtD
Cyclizine—CYP2C9—Guanfacine—hypertension	0.0154	0.0951	CbGbCtD
Cyclizine—CYP2C9—Candesartan—hypertension	0.0154	0.0951	CbGbCtD
Cyclizine—Phenoxybenzamine—Bepridil—hypertension	0.0151	0.0576	CrCrCtD
Cyclizine—Diphenidol—Bepridil—hypertension	0.0151	0.0576	CrCrCtD
Cyclizine—Diphenylpyraline—Bepridil—hypertension	0.0144	0.0549	CrCrCtD
Cyclizine—Fentanyl—Bepridil—hypertension	0.0134	0.0513	CrCrCtD
Cyclizine—Fentanyl—Quinapril—hypertension	0.0131	0.05	CrCrCtD
Cyclizine—Fentanyl—Benazepril—hypertension	0.0128	0.0488	CrCrCtD
Cyclizine—CYP2C9—Diltiazem—hypertension	0.0117	0.0721	CbGbCtD
Cyclizine—CYP2C9—Valsartan—hypertension	0.0107	0.0659	CbGbCtD
Cyclizine—Benzphetamine—Bepridil—hypertension	0.0105	0.0403	CrCrCtD
Cyclizine—Benzyl Benzoate—Bepridil—hypertension	0.00977	0.0374	CrCrCtD
Cyclizine—CYP2C9—Irbesartan—hypertension	0.00952	0.0587	CbGbCtD
Cyclizine—Diphenhydramine—Bepridil—hypertension	0.00937	0.0358	CrCrCtD
Cyclizine—CYP2C9—Amlodipine—hypertension	0.00934	0.0576	CbGbCtD
Cyclizine—Benzyl Benzoate—Benazepril—hypertension	0.0093	0.0355	CrCrCtD
Cyclizine—CYP2C9—Felodipine—hypertension	0.009	0.0556	CbGbCtD
Cyclizine—CYP2C9—Nifedipine—hypertension	0.00871	0.0537	CbGbCtD
Cyclizine—CYP2C9—Carvedilol—hypertension	0.00857	0.0529	CbGbCtD
Cyclizine—CYP2C9—Nicardipine—hypertension	0.00857	0.0529	CbGbCtD
Cyclizine—Atomoxetine—Propranolol—hypertension	0.00836	0.032	CrCrCtD
Cyclizine—CYP2C9—Atorvastatin—hypertension	0.00671	0.0414	CbGbCtD
Cyclizine—CYP2C9—Losartan—hypertension	0.00613	0.0379	CbGbCtD
Cyclizine—CYP2C9—Verapamil—hypertension	0.00541	0.0334	CbGbCtD
Cyclizine—SULT1E1—myocardium—hypertension	0.00172	0.186	CbGeAlD
Cyclizine—SULT1E1—adrenal cortex—hypertension	0.00124	0.135	CbGeAlD
Cyclizine—SULT1E1—heart—hypertension	0.0012	0.13	CbGeAlD
Cyclizine—SULT1E1—cardiovascular system—hypertension	0.00113	0.123	CbGeAlD
Cyclizine—SULT1E1—adrenal gland—hypertension	0.000897	0.0971	CbGeAlD
Cyclizine—CYP2C9—urine—hypertension	0.00085	0.0921	CbGeAlD
Cyclizine—SULT1E1—endocrine gland—hypertension	0.000778	0.0842	CbGeAlD
Cyclizine—CYP2C9—heart—hypertension	0.000218	0.0236	CbGeAlD
Cyclizine—HRH1—smooth muscle tissue—hypertension	0.000213	0.0231	CbGeAlD
Cyclizine—HRH1—decidua—hypertension	0.000209	0.0226	CbGeAlD
Cyclizine—CYP2C9—cardiovascular system—hypertension	0.000206	0.0223	CbGeAlD
Cyclizine—HRH1—adrenal gland—hypertension	0.00016	0.0174	CbGeAlD
Cyclizine—Bepridil—KCNQ1—hypertension	0.000145	0.0487	CrCbGaD
Cyclizine—CYP2C9—endocrine gland—hypertension	0.000141	0.0153	CbGeAlD
Cyclizine—HRH1—endocrine gland—hypertension	0.000139	0.0151	CbGeAlD
Cyclizine—Atomoxetine—NPY1R—hypertension	0.000131	0.0442	CrCbGaD
Cyclizine—Reboxetine—SLC6A2—hypertension	0.000126	0.0423	CrCbGaD
Cyclizine—HRH1—central nervous system—hypertension	0.000125	0.0136	CbGeAlD
Cyclizine—Flunarizine—CALM2—hypertension	0.000123	0.0415	CrCbGaD
Cyclizine—Bepridil—CALM2—hypertension	0.000107	0.036	CrCbGaD
Cyclizine—Bepridil—ATP1A1—hypertension	8.77e-05	0.0295	CrCbGaD
Cyclizine—Bifonazole—CYP17A1—hypertension	8.6e-05	0.0289	CrCbGaD
Cyclizine—Phenoxybenzamine—CALM2—hypertension	8.34e-05	0.0281	CrCbGaD
Cyclizine—Flunarizine—CALM1—hypertension	7.94e-05	0.0267	CrCbGaD
Cyclizine—Bepridil—CALM1—hypertension	6.9e-05	0.0232	CrCbGaD
Cyclizine—Cyproheptadine—SLC6A2—hypertension	6.53e-05	0.022	CrCbGaD
Cyclizine—Cyproheptadine—HTR2B—hypertension	6.14e-05	0.0206	CrCbGaD
Cyclizine—Mianserin—ADRA2B—hypertension	5.64e-05	0.019	CrCbGaD
Cyclizine—Phenoxybenzamine—ADRA2B—hypertension	5.55e-05	0.0187	CrCbGaD
Cyclizine—Phenoxybenzamine—CALM1—hypertension	5.38e-05	0.0181	CrCbGaD
Cyclizine—Diphenylpyraline—SLC6A3—hypertension	5.28e-05	0.0178	CrCbGaD
Cyclizine—Benzphetamine—SLC6A2—hypertension	5.11e-05	0.0172	CrCbGaD
Cyclizine—Atomoxetine—SLC6A2—hypertension	5.06e-05	0.017	CrCbGaD
Cyclizine—Mianserin—SLC6A2—hypertension	4.95e-05	0.0167	CrCbGaD
Cyclizine—Reboxetine—SLC6A4—hypertension	4.78e-05	0.0161	CrCbGaD
Cyclizine—Mianserin—HTR2B—hypertension	4.65e-05	0.0156	CrCbGaD
Cyclizine—Insomnia—Trandolapril—hypertension	4.51e-05	0.000443	CcSEcCtD
Cyclizine—Tachycardia—Irbesartan—hypertension	4.5e-05	0.000442	CcSEcCtD
Cyclizine—Anaphylactic shock—Furosemide—hypertension	4.49e-05	0.000442	CcSEcCtD
Cyclizine—Asthenia—Propranolol—hypertension	4.49e-05	0.000442	CcSEcCtD
Cyclizine—Skin disorder—Perindopril—hypertension	4.49e-05	0.000441	CcSEcCtD
Cyclizine—Insomnia—Enalapril—hypertension	4.49e-05	0.000441	CcSEcCtD
Cyclizine—Mental disorder—Timolol—hypertension	4.48e-05	0.000441	CcSEcCtD
Cyclizine—Loxapine—ADRA2B—hypertension	4.48e-05	0.0151	CrCbGaD
Cyclizine—Paraesthesia—Trandolapril—hypertension	4.48e-05	0.00044	CcSEcCtD
Cyclizine—Skin disorder—Irbesartan—hypertension	4.47e-05	0.00044	CcSEcCtD
Cyclizine—Tension—Ramipril—hypertension	4.47e-05	0.00044	CcSEcCtD
Cyclizine—Hypersensitivity—Indapamide—hypertension	4.46e-05	0.000439	CcSEcCtD
Cyclizine—Hypersensitivity—Diltiazem—hypertension	4.46e-05	0.000439	CcSEcCtD
Cyclizine—Tachycardia—Hydrochlorothiazide—hypertension	4.46e-05	0.000439	CcSEcCtD
Cyclizine—Paraesthesia—Enalapril—hypertension	4.46e-05	0.000438	CcSEcCtD
Cyclizine—Erythema—Timolol—hypertension	4.45e-05	0.000438	CcSEcCtD
Cyclizine—Hypotension—Captopril—hypertension	4.45e-05	0.000437	CcSEcCtD
Cyclizine—Somnolence—Trandolapril—hypertension	4.43e-05	0.000436	CcSEcCtD
Cyclizine—Insomnia—Telmisartan—hypertension	4.43e-05	0.000435	CcSEcCtD
Cyclizine—Nervousness—Ramipril—hypertension	4.42e-05	0.000435	CcSEcCtD
Cyclizine—Hypersensitivity—Carvedilol—hypertension	4.42e-05	0.000435	CcSEcCtD
Cyclizine—Somnolence—Enalapril—hypertension	4.41e-05	0.000434	CcSEcCtD
Cyclizine—Nervous system disorder—Furosemide—hypertension	4.41e-05	0.000433	CcSEcCtD
Cyclizine—Paraesthesia—Telmisartan—hypertension	4.4e-05	0.000432	CcSEcCtD
Cyclizine—Muscle spasms—Ramipril—hypertension	4.38e-05	0.000431	CcSEcCtD
Cyclizine—Bifonazole—CYP19A1—hypertension	4.38e-05	0.0147	CrCbGaD
Cyclizine—Hypersensitivity—Doxazosin—hypertension	4.37e-05	0.00043	CcSEcCtD
Cyclizine—Tension—Timolol—hypertension	4.37e-05	0.00043	CcSEcCtD
Cyclizine—Pain—Clonidine—hypertension	4.37e-05	0.00043	CcSEcCtD
Cyclizine—Constipation—Clonidine—hypertension	4.37e-05	0.00043	CcSEcCtD
Cyclizine—Skin disorder—Furosemide—hypertension	4.36e-05	0.000429	CcSEcCtD
Cyclizine—Nervous system disorder—Betaxolol—hypertension	4.36e-05	0.000429	CcSEcCtD
Cyclizine—Somnolence—Telmisartan—hypertension	4.35e-05	0.000428	CcSEcCtD
Cyclizine—Asthenia—Indapamide—hypertension	4.35e-05	0.000427	CcSEcCtD
Cyclizine—Asthenia—Diltiazem—hypertension	4.35e-05	0.000427	CcSEcCtD
Cyclizine—Tachycardia—Betaxolol—hypertension	4.34e-05	0.000427	CcSEcCtD
Cyclizine—Anaphylactic shock—Losartan—hypertension	4.34e-05	0.000426	CcSEcCtD
Cyclizine—Nervousness—Timolol—hypertension	4.33e-05	0.000425	CcSEcCtD
Cyclizine—Skin disorder—Betaxolol—hypertension	4.32e-05	0.000425	CcSEcCtD
Cyclizine—Hypotension—Perindopril—hypertension	4.32e-05	0.000425	CcSEcCtD
Cyclizine—Hypersensitivity—Fosinopril—hypertension	4.32e-05	0.000425	CcSEcCtD
Cyclizine—Insomnia—Captopril—hypertension	4.31e-05	0.000423	CcSEcCtD
Cyclizine—Asthenia—Carvedilol—hypertension	4.3e-05	0.000423	CcSEcCtD
Cyclizine—Hypotension—Irbesartan—hypertension	4.3e-05	0.000423	CcSEcCtD
Cyclizine—Pruritus—Diltiazem—hypertension	4.29e-05	0.000422	CcSEcCtD
Cyclizine—Pruritus—Indapamide—hypertension	4.29e-05	0.000422	CcSEcCtD
Cyclizine—Paraesthesia—Captopril—hypertension	4.27e-05	0.00042	CcSEcCtD
Cyclizine—Headache—Metoprolol—hypertension	4.27e-05	0.00042	CcSEcCtD
Cyclizine—Headache—Guanabenz—hypertension	4.27e-05	0.00042	CcSEcCtD
Cyclizine—Hypotension—Hydrochlorothiazide—hypertension	4.27e-05	0.00042	CcSEcCtD
Cyclizine—Tremor—Ramipril—hypertension	4.27e-05	0.00042	CcSEcCtD
Cyclizine—Constipation—Trandolapril—hypertension	4.26e-05	0.000419	CcSEcCtD
Cyclizine—Hypersensitivity—Nifedipine—hypertension	4.26e-05	0.000419	CcSEcCtD
Cyclizine—Urticaria—Valsartan—hypertension	4.26e-05	0.000419	CcSEcCtD
Cyclizine—Chills—Lisinopril—hypertension	4.26e-05	0.000419	CcSEcCtD
Cyclizine—Asthenia—Doxazosin—hypertension	4.26e-05	0.000419	CcSEcCtD
Cyclizine—Nervous system disorder—Losartan—hypertension	4.25e-05	0.000418	CcSEcCtD
Cyclizine—Pruritus—Carvedilol—hypertension	4.24e-05	0.000417	CcSEcCtD
Cyclizine—Constipation—Enalapril—hypertension	4.24e-05	0.000417	CcSEcCtD
Cyclizine—Hypersensitivity—Verapamil—hypertension	4.24e-05	0.000417	CcSEcCtD
Cyclizine—Urticaria—Olmesartan—hypertension	4.24e-05	0.000417	CcSEcCtD
Cyclizine—Somnolence—Captopril—hypertension	4.23e-05	0.000416	CcSEcCtD
Cyclizine—Tachycardia—Losartan—hypertension	4.23e-05	0.000416	CcSEcCtD
Cyclizine—Clozapine—HRH3—hypertension	4.23e-05	0.0142	CrCbGaD
Cyclizine—Asthenia—Fosinopril—hypertension	4.21e-05	0.000414	CcSEcCtD
Cyclizine—Hypotension—Furosemide—hypertension	4.2e-05	0.000413	CcSEcCtD
Cyclizine—Pruritus—Doxazosin—hypertension	4.2e-05	0.000413	CcSEcCtD
Cyclizine—Vision blurred—Timolol—hypertension	4.2e-05	0.000413	CcSEcCtD
Cyclizine—Constipation—Telmisartan—hypertension	4.19e-05	0.000412	CcSEcCtD
Cyclizine—Pain—Telmisartan—hypertension	4.19e-05	0.000412	CcSEcCtD
Cyclizine—Agitation—Ramipril—hypertension	4.19e-05	0.000412	CcSEcCtD
Cyclizine—Insomnia—Perindopril—hypertension	4.18e-05	0.000411	CcSEcCtD
Cyclizine—Asthenia—Eplerenone—hypertension	4.18e-05	0.000411	CcSEcCtD
Cyclizine—Angioedema—Ramipril—hypertension	4.16e-05	0.000409	CcSEcCtD
Cyclizine—Mental disorder—Lisinopril—hypertension	4.16e-05	0.000409	CcSEcCtD
Cyclizine—Hypotension—Betaxolol—hypertension	4.16e-05	0.000409	CcSEcCtD
Cyclizine—Paraesthesia—Perindopril—hypertension	4.15e-05	0.000408	CcSEcCtD
Cyclizine—Asthenia—Nifedipine—hypertension	4.15e-05	0.000408	CcSEcCtD
Cyclizine—Pruritus—Fosinopril—hypertension	4.15e-05	0.000408	CcSEcCtD
Cyclizine—Dizziness—Propranolol—hypertension	4.14e-05	0.000407	CcSEcCtD
Cyclizine—Paraesthesia—Irbesartan—hypertension	4.14e-05	0.000407	CcSEcCtD
Cyclizine—Insomnia—Hydrochlorothiazide—hypertension	4.13e-05	0.000406	CcSEcCtD
Cyclizine—Asthenia—Verapamil—hypertension	4.13e-05	0.000406	CcSEcCtD
Cyclizine—Erythema—Lisinopril—hypertension	4.13e-05	0.000406	CcSEcCtD
Cyclizine—Pruritus—Eplerenone—hypertension	4.12e-05	0.000405	CcSEcCtD
Cyclizine—Somnolence—Perindopril—hypertension	4.11e-05	0.000404	CcSEcCtD
Cyclizine—Paraesthesia—Hydrochlorothiazide—hypertension	4.1e-05	0.000403	CcSEcCtD
Cyclizine—Somnolence—Irbesartan—hypertension	4.1e-05	0.000403	CcSEcCtD
Cyclizine—Pruritus—Nifedipine—hypertension	4.09e-05	0.000402	CcSEcCtD
Cyclizine—Pruritus—Verapamil—hypertension	4.07e-05	0.000401	CcSEcCtD
Cyclizine—Constipation—Captopril—hypertension	4.07e-05	0.0004	CcSEcCtD
Cyclizine—Angioedema—Timolol—hypertension	4.07e-05	0.0004	CcSEcCtD
Cyclizine—Somnolence—Hydrochlorothiazide—hypertension	4.06e-05	0.000399	CcSEcCtD
Cyclizine—Urticaria—Clonidine—hypertension	4.06e-05	0.000399	CcSEcCtD
Cyclizine—Tension—Lisinopril—hypertension	4.05e-05	0.000399	CcSEcCtD
Cyclizine—Hypotension—Losartan—hypertension	4.05e-05	0.000398	CcSEcCtD
Cyclizine—Benzatropine—SLC6A3—hypertension	4.05e-05	0.0136	CrCbGaD
Cyclizine—Paraesthesia—Furosemide—hypertension	4.03e-05	0.000397	CcSEcCtD
Cyclizine—Insomnia—Betaxolol—hypertension	4.02e-05	0.000396	CcSEcCtD
Cyclizine—Nervousness—Lisinopril—hypertension	4.01e-05	0.000395	CcSEcCtD
Cyclizine—Dizziness—Indapamide—hypertension	4.01e-05	0.000394	CcSEcCtD
Cyclizine—Dizziness—Diltiazem—hypertension	4.01e-05	0.000394	CcSEcCtD
Cyclizine—Somnolence—Furosemide—hypertension	3.99e-05	0.000393	CcSEcCtD
Cyclizine—Paraesthesia—Betaxolol—hypertension	3.99e-05	0.000393	CcSEcCtD
Cyclizine—Muscle spasms—Lisinopril—hypertension	3.97e-05	0.000391	CcSEcCtD
Cyclizine—Dizziness—Carvedilol—hypertension	3.97e-05	0.00039	CcSEcCtD
Cyclizine—Urticaria—Trandolapril—hypertension	3.96e-05	0.000389	CcSEcCtD
Cyclizine—Constipation—Perindopril—hypertension	3.95e-05	0.000389	CcSEcCtD
Cyclizine—Pain—Perindopril—hypertension	3.95e-05	0.000389	CcSEcCtD
Cyclizine—Hypersensitivity—Valsartan—hypertension	3.95e-05	0.000388	CcSEcCtD
Cyclizine—Convulsion—Ramipril—hypertension	3.95e-05	0.000388	CcSEcCtD
Cyclizine—Urticaria—Enalapril—hypertension	3.94e-05	0.000388	CcSEcCtD
Cyclizine—Pain—Irbesartan—hypertension	3.94e-05	0.000387	CcSEcCtD
Cyclizine—Constipation—Irbesartan—hypertension	3.94e-05	0.000387	CcSEcCtD
Cyclizine—Loxapine—SLC6A2—hypertension	3.93e-05	0.0132	CrCbGaD
Cyclizine—Dizziness—Doxazosin—hypertension	3.92e-05	0.000386	CcSEcCtD
Cyclizine—Insomnia—Losartan—hypertension	3.92e-05	0.000386	CcSEcCtD
Cyclizine—Constipation—Hydrochlorothiazide—hypertension	3.91e-05	0.000384	CcSEcCtD
Cyclizine—Pain—Hydrochlorothiazide—hypertension	3.91e-05	0.000384	CcSEcCtD
Cyclizine—Vision blurred—Lisinopril—hypertension	3.89e-05	0.000383	CcSEcCtD
Cyclizine—Paraesthesia—Losartan—hypertension	3.89e-05	0.000383	CcSEcCtD
Cyclizine—Urticaria—Telmisartan—hypertension	3.89e-05	0.000382	CcSEcCtD
Cyclizine—Dizziness—Fosinopril—hypertension	3.88e-05	0.000381	CcSEcCtD
Cyclizine—Tremor—Lisinopril—hypertension	3.87e-05	0.000381	CcSEcCtD
Cyclizine—Orphenadrine—SLC6A2—hypertension	3.87e-05	0.013	CrCbGaD
Cyclizine—Somnolence—Losartan—hypertension	3.85e-05	0.000379	CcSEcCtD
Cyclizine—Dizziness—Eplerenone—hypertension	3.85e-05	0.000379	CcSEcCtD
Cyclizine—Asthenia—Valsartan—hypertension	3.85e-05	0.000378	CcSEcCtD
Cyclizine—Hypertension—Timolol—hypertension	3.84e-05	0.000378	CcSEcCtD
Cyclizine—Constipation—Furosemide—hypertension	3.84e-05	0.000378	CcSEcCtD
Cyclizine—Pain—Furosemide—hypertension	3.84e-05	0.000378	CcSEcCtD
Cyclizine—Asthenia—Olmesartan—hypertension	3.83e-05	0.000376	CcSEcCtD
Cyclizine—Dizziness—Nifedipine—hypertension	3.82e-05	0.000376	CcSEcCtD
Cyclizine—Dizziness—Verapamil—hypertension	3.81e-05	0.000374	CcSEcCtD
Cyclizine—Constipation—Betaxolol—hypertension	3.8e-05	0.000374	CcSEcCtD
Cyclizine—Pain—Betaxolol—hypertension	3.8e-05	0.000374	CcSEcCtD
Cyclizine—Headache—Indapamide—hypertension	3.8e-05	0.000373	CcSEcCtD
Cyclizine—Headache—Diltiazem—hypertension	3.8e-05	0.000373	CcSEcCtD
Cyclizine—Pruritus—Valsartan—hypertension	3.79e-05	0.000373	CcSEcCtD
Cyclizine—Angioedema—Lisinopril—hypertension	3.77e-05	0.000371	CcSEcCtD
Cyclizine—Pruritus—Olmesartan—hypertension	3.77e-05	0.000371	CcSEcCtD
Cyclizine—Hypersensitivity—Clonidine—hypertension	3.76e-05	0.00037	CcSEcCtD
Cyclizine—Clozapine—ADRA2B—hypertension	3.76e-05	0.0126	CrCbGaD
Cyclizine—Headache—Carvedilol—hypertension	3.76e-05	0.00037	CcSEcCtD
Cyclizine—Anaphylactic shock—Ramipril—hypertension	3.72e-05	0.000366	CcSEcCtD
Cyclizine—Headache—Doxazosin—hypertension	3.72e-05	0.000366	CcSEcCtD
Cyclizine—Pain—Losartan—hypertension	3.71e-05	0.000365	CcSEcCtD
Cyclizine—Constipation—Losartan—hypertension	3.71e-05	0.000365	CcSEcCtD
Cyclizine—Urticaria—Perindopril—hypertension	3.67e-05	0.000361	CcSEcCtD
Cyclizine—Headache—Fosinopril—hypertension	3.67e-05	0.000361	CcSEcCtD
Cyclizine—Hypersensitivity—Trandolapril—hypertension	3.67e-05	0.000361	CcSEcCtD
Cyclizine—Asthenia—Clonidine—hypertension	3.67e-05	0.000361	CcSEcCtD
Cyclizine—Urticaria—Irbesartan—hypertension	3.66e-05	0.00036	CcSEcCtD
Cyclizine—Hypersensitivity—Enalapril—hypertension	3.66e-05	0.00036	CcSEcCtD
Cyclizine—Headache—Eplerenone—hypertension	3.65e-05	0.000359	CcSEcCtD
Cyclizine—Nervous system disorder—Ramipril—hypertension	3.65e-05	0.000358	CcSEcCtD
Cyclizine—Anaphylactic shock—Timolol—hypertension	3.63e-05	0.000357	CcSEcCtD
Cyclizine—Urticaria—Hydrochlorothiazide—hypertension	3.63e-05	0.000357	CcSEcCtD
Cyclizine—Tachycardia—Ramipril—hypertension	3.63e-05	0.000357	CcSEcCtD
Cyclizine—Headache—Nifedipine—hypertension	3.62e-05	0.000356	CcSEcCtD
Cyclizine—Pruritus—Clonidine—hypertension	3.62e-05	0.000355	CcSEcCtD
Cyclizine—Skin disorder—Ramipril—hypertension	3.61e-05	0.000355	CcSEcCtD
Cyclizine—Headache—Verapamil—hypertension	3.61e-05	0.000355	CcSEcCtD
Cyclizine—Hypersensitivity—Telmisartan—hypertension	3.61e-05	0.000355	CcSEcCtD
Cyclizine—Benzphetamine—ADRA1A—hypertension	3.6e-05	0.0121	CrCbGaD
Cyclizine—Asthenia—Trandolapril—hypertension	3.58e-05	0.000352	CcSEcCtD
Cyclizine—Urticaria—Furosemide—hypertension	3.57e-05	0.000351	CcSEcCtD
Cyclizine—Nervous system disorder—Timolol—hypertension	3.56e-05	0.00035	CcSEcCtD
Cyclizine—Asthenia—Enalapril—hypertension	3.56e-05	0.00035	CcSEcCtD
Cyclizine—Dizziness—Valsartan—hypertension	3.54e-05	0.000349	CcSEcCtD
Cyclizine—Urticaria—Betaxolol—hypertension	3.53e-05	0.000348	CcSEcCtD
Cyclizine—Skin disorder—Timolol—hypertension	3.53e-05	0.000347	CcSEcCtD
Cyclizine—Dizziness—Olmesartan—hypertension	3.53e-05	0.000347	CcSEcCtD
Cyclizine—Pruritus—Trandolapril—hypertension	3.53e-05	0.000347	CcSEcCtD
Cyclizine—Asthenia—Telmisartan—hypertension	3.51e-05	0.000345	CcSEcCtD
Cyclizine—Pruritus—Enalapril—hypertension	3.51e-05	0.000345	CcSEcCtD
Cyclizine—Hypotension—Ramipril—hypertension	3.47e-05	0.000342	CcSEcCtD
Cyclizine—Pruritus—Telmisartan—hypertension	3.46e-05	0.000341	CcSEcCtD
Cyclizine—Urticaria—Losartan—hypertension	3.44e-05	0.000339	CcSEcCtD
Cyclizine—Phenoxybenzamine—ADRA1A—hypertension	3.44e-05	0.0116	CrCbGaD
Cyclizine—Asthenia—Captopril—hypertension	3.42e-05	0.000336	CcSEcCtD
Cyclizine—Hypotension—Timolol—hypertension	3.4e-05	0.000334	CcSEcCtD
Cyclizine—Hypersensitivity—Irbesartan—hypertension	3.39e-05	0.000334	CcSEcCtD
Cyclizine—Dizziness—Clonidine—hypertension	3.38e-05	0.000332	CcSEcCtD
Cyclizine—Anaphylactic shock—Lisinopril—hypertension	3.37e-05	0.000332	CcSEcCtD
Cyclizine—Pruritus—Captopril—hypertension	3.37e-05	0.000331	CcSEcCtD
Cyclizine—Hypersensitivity—Hydrochlorothiazide—hypertension	3.37e-05	0.000331	CcSEcCtD
Cyclizine—Insomnia—Ramipril—hypertension	3.36e-05	0.000331	CcSEcCtD
Cyclizine—Headache—Valsartan—hypertension	3.36e-05	0.00033	CcSEcCtD
Cyclizine—Headache—Olmesartan—hypertension	3.34e-05	0.000329	CcSEcCtD
Cyclizine—Paraesthesia—Ramipril—hypertension	3.34e-05	0.000328	CcSEcCtD
Cyclizine—Asthenia—Perindopril—hypertension	3.32e-05	0.000326	CcSEcCtD
Cyclizine—Hypersensitivity—Furosemide—hypertension	3.31e-05	0.000326	CcSEcCtD
Cyclizine—Asthenia—Irbesartan—hypertension	3.31e-05	0.000325	CcSEcCtD
Cyclizine—Somnolence—Ramipril—hypertension	3.3e-05	0.000325	CcSEcCtD
Cyclizine—Dizziness—Trandolapril—hypertension	3.3e-05	0.000324	CcSEcCtD
Cyclizine—Diphenhydramine—CYP2C18—hypertension	3.29e-05	0.0111	CrCbGaD
Cyclizine—Tachycardia—Lisinopril—hypertension	3.29e-05	0.000324	CcSEcCtD
Cyclizine—Insomnia—Timolol—hypertension	3.29e-05	0.000323	CcSEcCtD
Cyclizine—Dizziness—Enalapril—hypertension	3.28e-05	0.000323	CcSEcCtD
Cyclizine—Asthenia—Hydrochlorothiazide—hypertension	3.28e-05	0.000322	CcSEcCtD
Cyclizine—Hypersensitivity—Betaxolol—hypertension	3.28e-05	0.000322	CcSEcCtD
Cyclizine—Skin disorder—Lisinopril—hypertension	3.27e-05	0.000322	CcSEcCtD
Cyclizine—Pruritus—Perindopril—hypertension	3.27e-05	0.000322	CcSEcCtD
Cyclizine—Paraesthesia—Timolol—hypertension	3.26e-05	0.000321	CcSEcCtD
Cyclizine—Pruritus—Irbesartan—hypertension	3.26e-05	0.000321	CcSEcCtD
Cyclizine—Dizziness—Telmisartan—hypertension	3.24e-05	0.000318	CcSEcCtD
Cyclizine—Pruritus—Hydrochlorothiazide—hypertension	3.23e-05	0.000318	CcSEcCtD
Cyclizine—Somnolence—Timolol—hypertension	3.23e-05	0.000318	CcSEcCtD
Cyclizine—Asthenia—Furosemide—hypertension	3.22e-05	0.000317	CcSEcCtD
Cyclizine—Headache—Clonidine—hypertension	3.2e-05	0.000315	CcSEcCtD
Cyclizine—Hypersensitivity—Losartan—hypertension	3.19e-05	0.000314	CcSEcCtD
Cyclizine—Asthenia—Betaxolol—hypertension	3.19e-05	0.000314	CcSEcCtD
Cyclizine—Pruritus—Furosemide—hypertension	3.18e-05	0.000313	CcSEcCtD
Cyclizine—Constipation—Ramipril—hypertension	3.18e-05	0.000313	CcSEcCtD
Cyclizine—Hypotension—Lisinopril—hypertension	3.15e-05	0.00031	CcSEcCtD
Cyclizine—Dizziness—Captopril—hypertension	3.15e-05	0.00031	CcSEcCtD
Cyclizine—Pruritus—Betaxolol—hypertension	3.15e-05	0.000309	CcSEcCtD
Cyclizine—Headache—Trandolapril—hypertension	3.12e-05	0.000307	CcSEcCtD
Cyclizine—Modafinil—CYP3A5—hypertension	3.12e-05	0.0105	CrCbGaD
Cyclizine—Asthenia—Losartan—hypertension	3.11e-05	0.000306	CcSEcCtD
Cyclizine—Headache—Enalapril—hypertension	3.11e-05	0.000306	CcSEcCtD
Cyclizine—Pain—Timolol—hypertension	3.11e-05	0.000306	CcSEcCtD
Cyclizine—Pruritus—Losartan—hypertension	3.07e-05	0.000302	CcSEcCtD
Cyclizine—Headache—Telmisartan—hypertension	3.07e-05	0.000302	CcSEcCtD
Cyclizine—Dizziness—Perindopril—hypertension	3.06e-05	0.000301	CcSEcCtD
Cyclizine—Fentanyl—CYP3A5—hypertension	3.05e-05	0.0103	CrCbGaD
Cyclizine—Insomnia—Lisinopril—hypertension	3.05e-05	0.0003	CcSEcCtD
Cyclizine—Dizziness—Irbesartan—hypertension	3.05e-05	0.0003	CcSEcCtD
Cyclizine—Paraesthesia—Lisinopril—hypertension	3.03e-05	0.000298	CcSEcCtD
Cyclizine—Dizziness—Hydrochlorothiazide—hypertension	3.02e-05	0.000297	CcSEcCtD
Cyclizine—Somnolence—Lisinopril—hypertension	3e-05	0.000295	CcSEcCtD
Cyclizine—Modafinil—SLC6A3—hypertension	3e-05	0.0101	CrCbGaD
Cyclizine—Prochlorperazine—DRD3—hypertension	2.99e-05	0.0101	CrCbGaD
Cyclizine—Headache—Captopril—hypertension	2.98e-05	0.000293	CcSEcCtD
Cyclizine—Dizziness—Furosemide—hypertension	2.97e-05	0.000292	CcSEcCtD
Cyclizine—Urticaria—Ramipril—hypertension	2.95e-05	0.00029	CcSEcCtD
Cyclizine—Dizziness—Betaxolol—hypertension	2.94e-05	0.000289	CcSEcCtD
Cyclizine—Headache—Perindopril—hypertension	2.9e-05	0.000285	CcSEcCtD
Cyclizine—Urticaria—Timolol—hypertension	2.89e-05	0.000284	CcSEcCtD
Cyclizine—Headache—Irbesartan—hypertension	2.89e-05	0.000284	CcSEcCtD
Cyclizine—Pain—Lisinopril—hypertension	2.88e-05	0.000284	CcSEcCtD
Cyclizine—Constipation—Lisinopril—hypertension	2.88e-05	0.000284	CcSEcCtD
Cyclizine—Mianserin—HTR7—hypertension	2.88e-05	0.00969	CrCbGaD
Cyclizine—Dizziness—Losartan—hypertension	2.87e-05	0.000282	CcSEcCtD
Cyclizine—Headache—Hydrochlorothiazide—hypertension	2.86e-05	0.000281	CcSEcCtD
Cyclizine—Atomoxetine—HTR1B—hypertension	2.85e-05	0.0096	CrCbGaD
Cyclizine—Headache—Furosemide—hypertension	2.81e-05	0.000277	CcSEcCtD
Cyclizine—Headache—Betaxolol—hypertension	2.79e-05	0.000274	CcSEcCtD
Cyclizine—Loxapine—ADRA1A—hypertension	2.77e-05	0.00932	CrCbGaD
Cyclizine—Hypersensitivity—Ramipril—hypertension	2.74e-05	0.000269	CcSEcCtD
Cyclizine—Headache—Losartan—hypertension	2.72e-05	0.000267	CcSEcCtD
Cyclizine—Mianserin—DRD3—hypertension	2.71e-05	0.00911	CrCbGaD
Cyclizine—Urticaria—Lisinopril—hypertension	2.68e-05	0.000263	CcSEcCtD
Cyclizine—Hypersensitivity—Timolol—hypertension	2.68e-05	0.000263	CcSEcCtD
Cyclizine—Asthenia—Ramipril—hypertension	2.67e-05	0.000262	CcSEcCtD
Cyclizine—Pruritus—Ramipril—hypertension	2.63e-05	0.000259	CcSEcCtD
Cyclizine—Asthenia—Timolol—hypertension	2.61e-05	0.000256	CcSEcCtD
Cyclizine—Benzphetamine—SLC6A3—hypertension	2.6e-05	0.00874	CrCbGaD
Cyclizine—Flunarizine—CYP1A1—hypertension	2.59e-05	0.00871	CrCbGaD
Cyclizine—Atomoxetine—SLC6A3—hypertension	2.58e-05	0.00867	CrCbGaD
Cyclizine—Pruritus—Timolol—hypertension	2.57e-05	0.000253	CcSEcCtD
Cyclizine—Benzphetamine—ADRA2A—hypertension	2.55e-05	0.00857	CrCbGaD
Cyclizine—Mianserin—SLC6A3—hypertension	2.52e-05	0.00848	CrCbGaD
Cyclizine—Hypersensitivity—Lisinopril—hypertension	2.48e-05	0.000244	CcSEcCtD
Cyclizine—Cyproheptadine—DRD2—hypertension	2.47e-05	0.00832	CrCbGaD
Cyclizine—Mianserin—ADRA2A—hypertension	2.47e-05	0.00831	CrCbGaD
Cyclizine—Dizziness—Ramipril—hypertension	2.46e-05	0.000242	CcSEcCtD
Cyclizine—Phenoxybenzamine—ADRA2A—hypertension	2.43e-05	0.00819	CrCbGaD
Cyclizine—Asthenia—Lisinopril—hypertension	2.42e-05	0.000238	CcSEcCtD
Cyclizine—Dizziness—Timolol—hypertension	2.4e-05	0.000236	CcSEcCtD
Cyclizine—Pruritus—Lisinopril—hypertension	2.39e-05	0.000235	CcSEcCtD
Cyclizine—Headache—Ramipril—hypertension	2.33e-05	0.000229	CcSEcCtD
Cyclizine—Clozapine—ADRA1A—hypertension	2.33e-05	0.00783	CrCbGaD
Cyclizine—Loxapine—HTR7—hypertension	2.29e-05	0.0077	CrCbGaD
Cyclizine—Headache—Timolol—hypertension	2.28e-05	0.000224	CcSEcCtD
Cyclizine—Dizziness—Lisinopril—hypertension	2.23e-05	0.000219	CcSEcCtD
Cyclizine—Loxapine—HTR1B—hypertension	2.22e-05	0.00745	CrCbGaD
Cyclizine—Cinnarizine—DRD2—hypertension	2.16e-05	0.00725	CrCbGaD
Cyclizine—Loxapine—DRD3—hypertension	2.15e-05	0.00724	CrCbGaD
Cyclizine—Headache—Lisinopril—hypertension	2.11e-05	0.000208	CcSEcCtD
Cyclizine—Prochlorperazine—DRD2—hypertension	2.07e-05	0.00697	CrCbGaD
Cyclizine—Cinnarizine—CYP1A1—hypertension	2.05e-05	0.00689	CrCbGaD
Cyclizine—Phenoxybenzamine—ADRB2—hypertension	2.04e-05	0.00688	CrCbGaD
Cyclizine—Loxapine—SLC6A3—hypertension	2e-05	0.00673	CrCbGaD
Cyclizine—Loxapine—ADRA2A—hypertension	1.96e-05	0.0066	CrCbGaD
Cyclizine—Loxapine—ADRB1—hypertension	1.96e-05	0.00659	CrCbGaD
Cyclizine—Atomoxetine—SLC6A4—hypertension	1.93e-05	0.00648	CrCbGaD
Cyclizine—Clozapine—HTR7—hypertension	1.92e-05	0.00646	CrCbGaD
Cyclizine—Cyproheptadine—HTR2A—hypertension	1.91e-05	0.00643	CrCbGaD
Cyclizine—Mianserin—SLC6A4—hypertension	1.88e-05	0.00634	CrCbGaD
Cyclizine—Mianserin—DRD2—hypertension	1.87e-05	0.0063	CrCbGaD
Cyclizine—Clozapine—HTR1B—hypertension	1.86e-05	0.00626	CrCbGaD
Cyclizine—Clozapine—DRD3—hypertension	1.81e-05	0.00607	CrCbGaD
Cyclizine—Clozapine—ADRA2A—hypertension	1.65e-05	0.00554	CrCbGaD
Cyclizine—Phenprocoumon—ALB—hypertension	1.62e-05	0.00546	CrCbGaD
Cyclizine—Diphenhydramine—PTGS1—hypertension	1.61e-05	0.00541	CrCbGaD
Cyclizine—Loxapine—SLC6A4—hypertension	1.5e-05	0.00503	CrCbGaD
Cyclizine—Loxapine—DRD2—hypertension	1.49e-05	0.00501	CrCbGaD
Cyclizine—Atomoxetine—HTR2A—hypertension	1.48e-05	0.00498	CrCbGaD
Cyclizine—Mianserin—HTR2A—hypertension	1.45e-05	0.00487	CrCbGaD
Cyclizine—Clozapine—DRD2—hypertension	1.25e-05	0.0042	CrCbGaD
Cyclizine—Clozapine—CYP1A1—hypertension	1.19e-05	0.00399	CrCbGaD
Cyclizine—Loxapine—HTR2A—hypertension	1.15e-05	0.00387	CrCbGaD
Cyclizine—Clozapine—HTR2A—hypertension	9.65e-06	0.00325	CrCbGaD
Cyclizine—HRH1—GPCR downstream signaling—PRKCG—hypertension	5.86e-06	0.000112	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GNAS—hypertension	5.85e-06	0.000112	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HRH3—hypertension	5.85e-06	0.000111	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—XDH—hypertension	5.83e-06	0.000111	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PRKCA—hypertension	5.82e-06	0.000111	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTGIS—hypertension	5.72e-06	0.000109	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP3A5—hypertension	5.72e-06	0.000109	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC5A2—hypertension	5.72e-06	0.000109	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—EDN1—hypertension	5.64e-06	0.000107	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—hypertension	5.62e-06	0.000107	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CCL5—hypertension	5.6e-06	0.000107	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CCR5—hypertension	5.55e-06	0.000106	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PRKCD—hypertension	5.55e-06	0.000106	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TPH1—hypertension	5.52e-06	0.000105	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HSD11B1—hypertension	5.52e-06	0.000105	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—UCP2—hypertension	5.52e-06	0.000105	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—UCP3—hypertension	5.52e-06	0.000105	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ABCC1—hypertension	5.52e-06	0.000105	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NCF2—hypertension	5.44e-06	0.000104	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—HTR2A—hypertension	5.43e-06	0.000104	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—C3—hypertension	5.43e-06	0.000103	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADCY5—hypertension	5.36e-06	0.000102	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—hypertension	5.35e-06	0.000102	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALAS1—hypertension	5.35e-06	0.000102	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC2A3—hypertension	5.35e-06	0.000102	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP11B2—hypertension	5.35e-06	0.000102	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PRKCG—hypertension	5.32e-06	0.000101	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NPY—hypertension	5.3e-06	0.000101	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VWF—hypertension	5.3e-06	0.000101	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PRKCA—hypertension	5.28e-06	0.000101	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ADA—hypertension	5.27e-06	0.0001	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HSD3B1—hypertension	5.27e-06	0.0001	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AQP1—hypertension	5.19e-06	9.9e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—FADS1—hypertension	5.19e-06	9.9e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AGT—hypertension	5.15e-06	9.82e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—hypertension	5.11e-06	9.74e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AGTR2—hypertension	5.11e-06	9.74e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—OXT—hypertension	5.11e-06	9.74e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR1B—hypertension	5.11e-06	9.74e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCL2—hypertension	5.11e-06	9.74e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TGFBR1—hypertension	5.05e-06	9.63e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—F2R—hypertension	5.05e-06	9.63e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CA9—hypertension	5.05e-06	9.63e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TBXAS1—hypertension	5.05e-06	9.63e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CCR5—hypertension	5.04e-06	9.61e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PRKCD—hypertension	5.04e-06	9.61e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—hypertension	4.99e-06	9.5e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—hypertension	4.94e-06	9.41e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HTR2A—hypertension	4.93e-06	9.4e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—C3—hypertension	4.93e-06	9.39e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALOX5AP—hypertension	4.92e-06	9.38e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALOX15—hypertension	4.92e-06	9.38e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EDNRB—hypertension	4.89e-06	9.33e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NCF1—hypertension	4.89e-06	9.33e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—hypertension	4.86e-06	9.26e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TAC1—hypertension	4.84e-06	9.23e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LHB—hypertension	4.81e-06	9.16e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HADHA—hypertension	4.81e-06	9.16e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PRKCB—hypertension	4.76e-06	9.08e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—F2—hypertension	4.76e-06	9.08e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCR3—hypertension	4.75e-06	9.05e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ANXA1—hypertension	4.75e-06	9.05e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IKBKB—hypertension	4.71e-06	8.97e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LPA—hypertension	4.7e-06	8.95e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—KCNJ11—hypertension	4.7e-06	8.95e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HSD3B2—hypertension	4.7e-06	8.95e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AGT—hypertension	4.68e-06	8.92e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SST—hypertension	4.62e-06	8.81e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EDNRA—hypertension	4.62e-06	8.81e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CALM1—hypertension	4.6e-06	8.77e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DRD3—hypertension	4.6e-06	8.77e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CYBA—hypertension	4.6e-06	8.77e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRB1—hypertension	4.6e-06	8.77e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FLT1—hypertension	4.6e-06	8.77e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRA2A—hypertension	4.52e-06	8.62e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—hypertension	4.52e-06	8.61e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GHRL—hypertension	4.5e-06	8.58e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PLAT—hypertension	4.5e-06	8.58e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP2C18—hypertension	4.5e-06	8.58e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LRP2—hypertension	4.5e-06	8.58e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CALCA—hypertension	4.45e-06	8.48e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—hypertension	4.37e-06	8.33e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—BDKRB2—hypertension	4.35e-06	8.28e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—POMC—hypertension	4.34e-06	8.27e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HSPG2—hypertension	4.33e-06	8.26e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—F2—hypertension	4.33e-06	8.24e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PRKCB—hypertension	4.33e-06	8.24e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRBK1—hypertension	4.3e-06	8.19e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—hypertension	4.29e-06	8.17e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CNR1—hypertension	4.27e-06	8.13e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—hypertension	4.25e-06	8.09e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—hypertension	4.24e-06	8.07e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CALM2—hypertension	4.22e-06	8.04e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GLP1R—hypertension	4.19e-06	7.98e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALOX5—hypertension	4.19e-06	7.98e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AKT2—hypertension	4.17e-06	7.95e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—DRD2—hypertension	4.16e-06	7.93e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR7—hypertension	4.16e-06	7.93e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GCG—hypertension	4.12e-06	7.85e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTPN1—hypertension	4.12e-06	7.85e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KL—hypertension	4.04e-06	7.7e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOTCH2—hypertension	4.04e-06	7.7e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ITGAV—hypertension	3.97e-06	7.56e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NGFR—hypertension	3.97e-06	7.56e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KNG1—hypertension	3.95e-06	7.53e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—POMC—hypertension	3.94e-06	7.51e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRL—hypertension	3.93e-06	7.49e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AGTR1—hypertension	3.93e-06	7.49e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—STK11—hypertension	3.87e-06	7.38e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HDAC1—hypertension	3.87e-06	7.38e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CCL2—hypertension	3.86e-06	7.35e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCL10—hypertension	3.84e-06	7.32e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PLG—hypertension	3.83e-06	7.3e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALDH2—hypertension	3.83e-06	7.3e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—RHOA—hypertension	3.82e-06	7.29e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AKT2—hypertension	3.79e-06	7.22e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3R1—hypertension	3.78e-06	7.21e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—hypertension	3.73e-06	7.11e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HBA1—hypertension	3.73e-06	7.11e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRB2—hypertension	3.73e-06	7.1e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP11A1—hypertension	3.71e-06	7.07e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypertension	3.68e-06	7.01e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKCE—hypertension	3.68e-06	7.01e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTT1—hypertension	3.64e-06	6.94e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC9A1—hypertension	3.64e-06	6.94e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VAV3—hypertension	3.64e-06	6.93e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDGFA—hypertension	3.64e-06	6.93e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GCLC—hypertension	3.6e-06	6.86e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CETP—hypertension	3.6e-06	6.86e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TGFBR2—hypertension	3.58e-06	6.83e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GNB3—hypertension	3.55e-06	6.77e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AVP—hypertension	3.5e-06	6.67e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—RHOA—hypertension	3.47e-06	6.62e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GNAS—hypertension	3.46e-06	6.59e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP17A1—hypertension	3.45e-06	6.57e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3R1—hypertension	3.44e-06	6.55e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ENO1—hypertension	3.41e-06	6.5e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTGS1—hypertension	3.41e-06	6.5e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOB—hypertension	3.39e-06	6.45e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTK2—hypertension	3.37e-06	6.42e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CXCL8—hypertension	3.36e-06	6.4e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hypertension	3.36e-06	6.4e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EDN1—hypertension	3.33e-06	6.35e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCL5—hypertension	3.31e-06	6.3e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CTGF—hypertension	3.28e-06	6.26e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GOT2—hypertension	3.26e-06	6.2e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HMGCR—hypertension	3.26e-06	6.2e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LPL—hypertension	3.23e-06	6.16e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	3.21e-06	6.12e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—H2AFX—hypertension	3.21e-06	6.12e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RPS6KB1—hypertension	3.2e-06	6.1e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDGFRB—hypertension	3.2e-06	6.1e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ADRA2A—hypertension	3.19e-06	6.07e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADCY5—hypertension	3.16e-06	6.03e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKCG—hypertension	3.14e-06	5.99e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ITGB3—hypertension	3.12e-06	5.95e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKCA—hypertension	3.12e-06	5.95e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—YWHAZ—hypertension	3.1e-06	5.9e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SPP1—hypertension	3.06e-06	5.83e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NGF—hypertension	3.06e-06	5.83e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CXCL8—hypertension	3.05e-06	5.81e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—TH—hypertension	2.98e-06	5.68e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKCD—hypertension	2.98e-06	5.67e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCR5—hypertension	2.98e-06	5.67e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CALM2—hypertension	2.97e-06	5.66e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—hypertension	2.94e-06	5.6e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR2A—hypertension	2.91e-06	5.55e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—C3—hypertension	2.91e-06	5.55e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GCG—hypertension	2.9e-06	5.53e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC2A4—hypertension	2.9e-06	5.53e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PDGFB—hypertension	2.83e-06	5.4e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGFR1—hypertension	2.82e-06	5.37e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GOT1—hypertension	2.81e-06	5.35e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HIF1A—hypertension	2.78e-06	5.29e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AGT—hypertension	2.77e-06	5.27e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP19A1—hypertension	2.73e-06	5.2e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—STK11—hypertension	2.73e-06	5.2e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CALM1—hypertension	2.72e-06	5.18e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LEP—hypertension	2.71e-06	5.16e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOE—hypertension	2.71e-06	5.16e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CAV1—hypertension	2.68e-06	5.12e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOA1—hypertension	2.68e-06	5.1e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—KDR—hypertension	2.65e-06	5.06e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hypertension	2.56e-06	4.88e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—F2—hypertension	2.56e-06	4.87e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKCB—hypertension	2.56e-06	4.87e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FN1—hypertension	2.56e-06	4.87e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—COMT—hypertension	2.54e-06	4.83e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPARGC1A—hypertension	2.5e-06	4.77e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GNB3—hypertension	2.5e-06	4.77e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOTCH1—hypertension	2.5e-06	4.76e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HMOX1—hypertension	2.49e-06	4.74e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CAT—hypertension	2.46e-06	4.68e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hypertension	2.44e-06	4.65e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GNAS—hypertension	2.43e-06	4.64e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOB—hypertension	2.38e-06	4.54e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—POMC—hypertension	2.33e-06	4.44e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTM1—hypertension	2.32e-06	4.42e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—INS—hypertension	2.31e-06	4.41e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCL2—hypertension	2.28e-06	4.34e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LPL—hypertension	2.28e-06	4.34e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IGF1—hypertension	2.24e-06	4.27e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKT2—hypertension	2.24e-06	4.26e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ADCY5—hypertension	2.23e-06	4.25e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—EGFR—hypertension	2.23e-06	4.25e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GPX1—hypertension	2.22e-06	4.23e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PRKCA—hypertension	2.2e-06	4.19e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP1A1—hypertension	2.2e-06	4.19e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CD36—hypertension	2.16e-06	4.12e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SERPINE1—hypertension	2.13e-06	4.05e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—FGF2—hypertension	2.06e-06	3.92e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RHOA—hypertension	2.05e-06	3.91e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MTHFR—hypertension	2.05e-06	3.91e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3R1—hypertension	2.03e-06	3.87e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOS3—hypertension	2.03e-06	3.87e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPARA—hypertension	2.01e-06	3.83e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AGT—hypertension	1.95e-06	3.71e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CALM1—hypertension	1.92e-06	3.65e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RELA—hypertension	1.91e-06	3.64e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOE—hypertension	1.91e-06	3.64e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CAV1—hypertension	1.89e-06	3.6e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOA1—hypertension	1.89e-06	3.59e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MTOR—hypertension	1.87e-06	3.57e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CXCL8—hypertension	1.8e-06	3.43e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AKT1—hypertension	1.74e-06	3.31e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6—hypertension	1.71e-06	3.26e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPARG—hypertension	1.66e-06	3.17e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—POMC—hypertension	1.64e-06	3.12e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—INS—hypertension	1.63e-06	3.11e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MMP9—hypertension	1.63e-06	3.1e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CDKN1A—hypertension	1.62e-06	3.09e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTEN—hypertension	1.62e-06	3.09e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MAPK8—hypertension	1.58e-06	3.02e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AKT1—hypertension	1.58e-06	3.01e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EP300—hypertension	1.54e-06	2.94e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SRC—hypertension	1.5e-06	2.86e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALB—hypertension	1.49e-06	2.85e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VEGFA—hypertension	1.46e-06	2.79e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3R1—hypertension	1.43e-06	2.72e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NOS3—hypertension	1.43e-06	2.72e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MYC—hypertension	1.35e-06	2.56e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TGFB1—hypertension	1.34e-06	2.56e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EGFR—hypertension	1.32e-06	2.51e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTGS2—hypertension	1.31e-06	2.49e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTEN—hypertension	1.14e-06	2.17e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TP53—hypertension	1.1e-06	2.11e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—EP300—hypertension	1.09e-06	2.07e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6—hypertension	1.01e-06	1.93e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKT1—hypertension	9.33e-07	1.78e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKT1—hypertension	6.57e-07	1.25e-05	CbGpPWpGaD
